In recent months, the U.S. Food and Drug Administration has taken a closer look at products containing CBD oil—even going so far as to send companies warning letters about how they label their products, threatening to take action if the companies do not comply with federal standards.
In other words, the FDA doesn’t want manufacturing companies making drug claims or stating that CBD oil can treat, mitigate, cure or prevent disease in patients taking them. Manufacturers who were making such claims were told to remove these claims or else.
Additionally, the FDA has concluded that CBD products cannot be labelled as supplements, but rather a “new drug.”
According to the FDA: “New drugs may not be legally introduced or delivered for introduction into interstate commerce without prior approval from the FDA….FDA approves a new drug on the basis of scientific data and information demonstrating that the drug is safe and effective.”
The problem with this ruling that CBD oil products, including those used for food and dietary supplements, were on the market for some time before the FDA required the formulations to be submitted for testing. These products, therefore, are exempt from such laws.
The bigger issue that has arisen involves hemp-derived CBD oils, which are not covered.
There’s much more on this story. Continue reading…